Biomarker-Guided Neuromodulation for Psychiatric Disorders скачать в хорошем качестве

Biomarker-Guided Neuromodulation for Psychiatric Disorders

Speaker: Corey Keller, MD, PhD • Assistant Professor • Dept. of Psychiatry and Behavioral Sciences • Stanford Univ. ________ Learning objectives: Upon completion of this activity, participants will be able to: • Describe three key limitations of current transcranial magnetic stimulation (TMS) treatments for depression and explain how biomarker-guided approaches could address these limitations • Identify five different brain stimulation modalities used in interventional psychiatry and their respective clinical applications • Explain the mechanism and clinical significance of TMS-evoked potentials (TEPs) as potential biomarkers for TMS treatment response in depression ________ Psychiatry and Behavioral Sciences Grand Rounds presentations are for educational purposes and intended only for behavioral/mental health professionals and clinical providers. The views, thoughts, and opinions expressed are the speaker’s own and do not imply any endorsement of any particular viewpoints, positions, products, services, or organizations by the Department of Psychiatry and Behavioral Sciences, UC San Francisco, or the Regents of the University of California.